Why peptide ordering is a catalog-and-routing problem
Peptide programs are wide. Beyond the headline molecules like sermorelin and NAD+, clinics order a long tail of compounds, and not every 503A pharmacy makes every peptide. That turns ordering into two questions: how deep is the catalog you can actually reach, and how cleanly does a multi-SKU order route when different molecules live behind different compounders. Refill connects you to 503A pharmacies that compound peptides, but the specific molecules, concentrations, and rates depend on the partner network, so confirm catalog breadth directly rather than assuming any single peptide is stocked.
This page is about ordering workflow, not clinical protocols. Which peptides a clinic offers is a prescriber and program decision; the platform's job is to surface what is available, route each line to the right pharmacy, and show what each costs. What you should evaluate is whether the platform exposes a deep, searchable catalog with repeat-SKU favorites and clean multi-pharmacy routing.